Immunohistochemical staining for markers of future neoplastic progression in the larynx

Cancer Research

Volumn 56, Issue 9, 1996, Pages 2199-2205

  Uhlman, Dorothy L ^a,d   Adams, George ^b   Knapp, Dennis ^c   Aeppli, Dorothee M ^b   Niehans, Gloria ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; EPIDERMAL GROWTH FACTOR;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL TRANSFORMATION; GENE EXPRESSION; GENETIC STABILITY; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL;

ADULT; AGED; CARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029877717     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Rothman, K. J. The effect of alcohol consumption on risk of cancer of the head and neck. Laryngoscope, 88: 51-55, 1978.
2. Mincer, H H., Coleman, S. A., and Hopkins, K. P Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg., 33: 389-399, 1972.
3. Santini, J., Formento, J-L , Francoual, M., Milano, G., Schneider, M., Dassonville, O., and Demard, F. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head & Neck, 13: 132-139, 1991
4. Shin, D. M., Ro, J. Y., Hong, W. K., and Hittelman, W. N. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res., 54 3153-3159, 1994.
5. Bergler, W , Bier, H , and Ganzer, H. The expression of epidermal growth factor receptors in the oral mucosa of patients with oral cancer. Arch. Oto-rhino-laryngol., 246: 121-125, 1989
6. Di Fiore, P P , Pierce, J H , Fleming, T. P., Hazan, R., Ullrich, A , King, C. R., Schlessinger, J , and Aaronson, S. A. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell. 51: 1063-1070, 1987
7. Gusterson, B. A., Anbazhagan, R., Warren, W., Midgely, C., Lane, D. P., O'Hare, M , Stamps, A , Carter, R., and Jayatilake, H. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene, 6: 1785-1789, 1991.
8. Boyle, J. O., Hakim, J , Koch, W., van der Riet, P., Hruban, R. H., Roa, A., Correo, R., Eby, Y. J., Ruppert J. M., and Sidransky, D The incidence of p53 mutations increases with progression of head and neck cancer Cancer Res., 53: 4477-4480, 1993
9. Nees, M , Homann, N , Discher, H., Andl, T , Enders, C., Herold-Mende, C., Schuhmann, A., and Bosch, F. X. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple rumors. Cancer Res , 53. 4189-4196, 1993.
10. Kuerbitz, S. J., Plunkett, B S , Walsh, W. V , and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation Proc Natl Acad. Sci USA, 89. 7491-7495, 1992.
11. Livingstone, L R , White, A., Sprouse, J., Livanos, E., Jacks, T., and Tisty, T. D Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70. 923-935, 1992.
12. Lippman, S. M , Shin, D. M , Lee, J. J., Batsakis, J. G., Lotan, R., Tainsky, M A., Hittelman, W. N , and Hong, W. K. p53 and retinoid chemoprevention of oral carcinogenesis Cancer Res , 55: 16-19, 1995.
13. 1. Genes & Dev., 7: 812-821, 1993.
14. Hinds, P W , Dowdy, S. F., Eaton, E. N , Arnold, A., and Weinberg, R. A. Function of a human cyclin gene as an oncogene Proc Natl. Acad. Sci. USA, 91. 709-713, 1994.
15. Jares, P., Fernandez, P. L , Campo, E., Nadal, A , Bosch, F , Aiza, G., Nayach, I , Traserra, J., and Cardesa, A. PRAD-1/crclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas Cancer Res , 54. 4813-4817, 1994.
16. 1 protein levels and cell proliferation in different stages of human esophgeal and gastric-cardia carcinogenesis. Int. J. Cancer, 59: 514-519, 1994
17. Hsu, S. M., Raine, L , and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidise techniques a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem Cytochem., 29: 577-580, 1981.
18. Visakorpi, T , Kallioniemi, O. P., Koivula, T., Harvey, J , and Isola, J. Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas. Mod. Pathol., 5: 643-648, 1992.
19. Banks, L , Matlashewski, G , and Crawford, L Isolation of human p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem., 159: 529-534, 1986
20. 1 overexpression m breast cancer. Oncogene, 11: 885-891, 1995.
21. Resnick, J M., Cherwitz, D., Knapp, D., Uhlman, D., and Niehans, G. A. A microwave method that enhances detection of aberrant p53 expression in formalin-fixed, paraffin-embedded tissues. Arch. Pathol Lab. Med., 119: 360-366, 1995.
22. Grandis, J. R., and Tweardy, D J. Elevated levels of transforming growth factor a and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res., 53: 3579-3584, 1993.
23. Dolcetti, R., Doglioni, C., Maestro, R. Gasparotto, D., Barzan, L., Pastore, A., Romanelli, M , and Boiocchi, M. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int. J. Cancer, 52: 178-182, 1992.
24. Kaur, J., Srivastava, A., and Ralhan, R. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India. Int. J. Cancer. 58. 340-345, 1994.
25. Walker, C , Robertson, L. J., Myskow, M. W., Pendleton, N., and Dixon, G. R. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br. J. Cancer. 70: 297-303, 1994.
26. Gao, H., Wang, L-D , Zhou, Q., Hong, J-Y., Huang, T-Y., and Yang, C. S. p53 tumor suppressor gene mutation in early esophageal precancerous lestons and carcinoma among high-risk populations in Henan, China. Cancer Res., 54: 4342-4346, 1994.
27. WAF1/CIPI expression in normal and neoplastic tissues. Cancer Res., 55: 2910-2919, 1995.
28. Voravud, N., Shin, D. M., Ro, J. Y., Lee, J. S., Hong, W. K., and Hitlelman, W. K. Increased polysemies of chromosome 7 and 17 during head and neck multistage tumorigenesis. Cancer Res., 53, 2874-2883, 1993